α-amylase activities of fraction in dichloromethane extract from the stem bark of Garcinia forbesii
暂无分享,去创建一个
[1] M. Taher,et al. Evaluation of the Antioxidant, Antidiabetic, and Antiplasmodial Activities of Xanthones Isolated from Garcinia forbesii and Their In Silico Studies , 2021, Biomedicines.
[2] S. Sutomo,et al. Pharmacognostic Study and Antioxidant Activity of Mundar (Garcinia forbesii King.) leaves from Banua Botanical Gardens of South Kalimantan , 2020 .
[3] A. Pugazhendhi,et al. Various solvent effects on phytochemical constituent profiles, analysis of antioxidant and antidiabetic activities of Hopea parviflora , 2020 .
[4] Sarah Cuschieri,et al. The genetic side of type 2 diabetes - A review. , 2019, Diabetes & metabolic syndrome.
[5] L. Huang,et al. Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America , 2019, Diabetology & Metabolic Syndrome.
[6] De-wen Yan,et al. The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis , 2018, BMJ Open.
[7] A. Afolayan,et al. In vitro α-amylase, α-glucosidase, lipase inhibitory and cytotoxic activities of tuber extracts of Kedrostis africana (L.) Cogn , 2018, Heliyon.
[8] Sofia Dahlqvist,et al. A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3) , 2018, Diabetes technology & therapeutics.
[9] Yu Cao,et al. Purification and characterization of a novel intracellular α-amylase with a wide variety of substrates hydrolysis and transglycosylation activity from Paenibacillus sp. SSG-1. , 2018, Protein expression and purification.
[10] Frank B. Hu,et al. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.
[11] S. Jayanty,et al. Inhibition of α-glucosidase, α-amylase, and aldose reductase by potato polyphenolic compounds , 2018, PloS one.
[12] E. Bonifacio,et al. Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis , 2016, Diabetes.
[13] G. Kahaly,et al. Type 1 diabetes associated autoimmunity. , 2016, Autoimmunity reviews.
[14] Amy Hui-Mei Lin,et al. Small intestine mucosal α-glucosidase: A missing feature of in vitro starch digestibility , 2016 .
[15] E. Kawasaki. Type 1 Diabetes and Autoimmunity , 2014, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.
[16] Dan Chen,et al. Rapid screening and identification of α-amylase inhibitors from Garcinia xanthochymus using enzyme-immobilized magnetic nanoparticles coupled with HPLC and MS. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[17] B. M. Pinto,et al. New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata. , 2010, Biochemistry.
[18] Melvin H. Williams,et al. Dietary Supplements and Sports Performance: Introduction and Vitamins , 2004, Journal of the International Society of Sports Nutrition.